Delivery Order SPE2DB20D9766-SPE2DB24FC1GK

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the blood coagulation factor KCENTRA, with a ceiling value of $60,532.48 and a completion date of February 22, 2024. The order was placed under DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA,...
This is a $27,408.64 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 1,000 unit vials of the blood coagulation factor Kcentra, with a performance period through May 7, 2024. The contract is issued under DMS Pharmaceutical Group's existing single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which supports the recurring...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,152.48 contract is for the delivery of 1,000 unit vials of the blood coagulation factor KCENTRA. The delivery order was issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA's Medical Supply Chain division. This IDC...
This is a delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,297.60 firm fixed-price contract is for the delivery of KCENTRA 500UNIT 1S, a pharmaceutical product, with a completion date of July 12, 2024. The contract is not set-aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $85,652.00, is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,838.08, is for the delivery of 4,565,818,278 units of KCENTRA 500 unit vials. The award is not associated with any set-aside designation. It is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $13,230.08, is for the supply of 1,000-unit vials of the pharmaceutical product KCENTRA. There is no set-aside designation for this award. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,408.64 firm fixed-price contract is for the supply of 1,000 unit vials of Kcentra, a blood coagulation factor. The award is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery orders for a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of KCENTRA 500 unit vials, with a ceiling value of $17,297.60. It is a firm fixed-price contract with no set-aside designation. The contract has an ultimate completion date of August 20, 2024 and was awarded on July 30, 2024. DMS Pharmaceutical Group is the prime contractor and...
  • SPE2DB20D9766
    Indefinite Delivery Contract
  • SPE2DB20D9766-SPE2DB24FC1GK
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $17,297.60 and runs through July 23, 2024.

The contract is for the delivery of KCENTRA 500 UNIT VIALS, a blood coagulation factor, to support the recurring medical supply needs of military health facilities. This contract is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to military healthcare sites worldwide. The contract does not have a set-aside designation.

Generated 9/30/24, 4:22 PM